Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025)
Equillium (EQ) reported Change in Acquisitions & Divestments of $4.5 million for Q1 2025, little changed year-over-year from $4.5 million in Q1 2024, and down 25.0% quarter-over-quarter from $6.0 million in Q4 2024.
Equillium (EQ) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends
Equillium (EQ) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $4.5 million in Q1 2025.
- Change in Acquisitions & Divestments for Q1 2025 came in at $4.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.5 million (down 85.71% YoY), and the FY2025 annual result was $4.5 million, down 85.71% from the prior year.
- Change in Acquisitions & Divestments retreated to $4.5 million in Q1 2025 per EQ's latest filing, from $6.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $29.0 million in Q2 2021 and troughed at $2.5 million in Q4 2021.
- A 5-year average of $10.6 million and a median of $11.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 79.94% in 2022, then surged 380.0% in 2023.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $2.5 million in 2021, then surged by 179.2% to $7.0 million in 2022, then jumped by 71.92% to $12.0 million in 2023, then sank by 50.0% to $6.0 million in 2024, then fell by 25.0% to $4.5 million in 2025.
- Business Quant data shows EQ's Change in Acquisitions & Divestments at $4.5 million in Q1 2025, $6.0 million in Q4 2024, and $12.0 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Sep 30, 2023 | 11.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Mar 31, 2023 | 12.00 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Dec 31, 2022 | 6.98 Mn |